Allergies Desert U.S.
- Product NDC
- 57955-2722
- 11-digit product format
- 579552722
- Labeler code
- 57955
- Product ID
- 57955-2722_f909e5b4-5ef8-48b7-9228-86a3a56e6fb4
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Alfalfa, Allium cepa, Ambrosia, Arum triph, Arundo mauritanica, Cortisone aceticum, Erechtites, Erigeron, Euonymus atrop, Euphrasia, Galphimia, Nat mur, RNA, Sabadilla, Stramonium, Triticum
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- King Bio Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2022-06-06
- Marketing end
- 0000-00-00
- Substance
- ADENOSINE CYCLIC PHOSPHATE; AMBROSIA ARTEMISIIFOLIA WHOLE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CORTICOTROPIN; CORTISONE ACETATE; DATURA STRAMONIUM; ELYMUS REPENS ROOT; EPINEPHRINE; ERECHTITES HIERACIIFOLIUS WHOLE; ERIGERON CANADENSIS WHOLE; EUONYMUS ATROPURPUREUS BRANCH BARK/ROOT BARK; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; MEDICAGO SATIVA WHOLE; ONION; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE
- Active strength
- 12 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 57955-2722 | D | Discontinued by firm | 2026-10-05 | ||
| excluded package | package | 57955-2722 | 57955-2722-2 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 57955-2722-2 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 57955-2722-2 | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 57955-2722-2 | 57955272202 | 59 mL in 1 BOTTLE, SPRAY (57955-2722-2) | 59 ml | 2022-06-06 | 0000-00-00 | No | No | Current |